About Us

Cellomatics Biosciences Ltd. is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas.

We provide bespoke pre-clinical/early discovery phase laboratory services to support Biotech, Pharmaceutical companies and Academic groups in their drug discovery projects. Our aim is to assist our clients in expediting their drug development programmes by providing high quality ethical services.

Cellomatics BioSciences is continually striving to offer added value to all our client discovery projects. We achieve this by constantly reviewing and evaluating new technologies that complement and augment our preclinical in vitro capabilities.

Key Facts -

  • Founded in 2015 and Privately owned
  • Operating out of Biocity, Nottingham
  • Experienced Management team with track record of delivering complex scientific projects
  • Links with leading UK Universities
  • Fully serviced laboratory with Specialised personnel

Who can we support


We are committed to

  • Understanding your needs and tailoring our services to meet your requests
  • Meeting your timelines
  • Providing interactive and efficient customer support
  • Delivering high quality services at a very cost effective price

Our Approach

How can we support you?

We offer a range of preclinical services:

TARGET VALIDATION We offer a range of strategies for modulating gene expression in vitro including the use of antibodies, negative dominant controls, antisense oligonucleotides,ribozymes and small-interfering RNAs.

IN VITRO CELL-BASED ASSAYS Cellomatics BioSciences also have expertise in designing, developing, performing and analysing functional cell-based assays using well-established cell lines and primary cells. We offer a comprehensive panel of cell-based functional assays using a vast selection of 2D and 3D cellular, co-culture models to determine the functional efficacy of your drug candidates.

BIOMARKER VALIDATION AND QUALIFICATION Molecular biomarkers are mainly used in early drug development, safety and proof of concept studies, as well as molecular profiling. Cellomatics BioSciences provides assay development and validation for prognostic/predictive clinical and pathway activation biomarkers:

  • Multiplex Immunoassay
  • Multiplex Nucleic Acid Testing
  • Western Blot
  • Clinical Chemistry Assays
  • In-Cell ELISA.

PREDICTIVE TOXICITY The main objective of pre-clinical testing is to determine the potential adverse effects, toxicity and drug/drug interactions before the drug is tested in either animal models or in a Phase 1 clinical trial. Hepato and renal in vitro toxicity tests are therefore vital for pre-screening drug compounds to reduce costs for in vivo testing and clinical trials. As the animal model might not mirror the human model completely, there is a powerful need to identify physiologically-relevant hepatic and kidney cellular models. Cellomatics BioSciences offers a vast selection of:

  • 2D and 3D cellular models
  • Biochemical
  • Metabolic and genetic assays to detect drug toxicity, ADME, pharmacokinetic and toxicogenomics.

CONSULTANCY In consultation with you, we can design strategies for the identification and validation of targets and biomarkers to support your drug discovery programs. Our team of experienced scientists can provide consultancy to assist you in designing, developing, optimizing and validating your assays for your target and biomarker qualification work. We will provide regular electronic updates on the progress of your projects.

REQUEST A CONSULTATION WITH CELLOMATICS BIOSCIENCES TODAY

Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.

To request a consultation where we can discuss your exact requirements, please contact Cellomatics BioSciences on
0115 787 0081 or email us at info@cellomaticsbio.com

Overview Of Our Project Management

At Cellomatics BioSciences, we believe in efficient Project Management to ensure delivery of a high-quality work and complete client satisfaction.

Every project is assigned a Project Manager and a Project Director: a two-step Quality control approach. The Project Manager is the central contact point throughout the project life cycle with day to day operational responsibilities and management of the project team to produce high quality deliverables. The Project Director has an overall responsibility for the timely execution and delivery of the project within the agreed budget.

Key Stages Of A Project Life Cycle:

Project Initiation

  • Defining Study Objectives
  • Finalisation of study design
  • Planning resources


Project Planning

  • Assigning roles and responsibilities
  • Scheduling the Project Plan
  • Assessing Risk & Mitigation/ Contingency Strategies
  • Planning communication schedules

Project Execution

  • Conduct studies
  • Regular internal and external project updates
  • Quality assurance/control
  • Time and cost management

Monitoring & Controlling

  • Project Status monitoring
  • Scope/Change Management

Project Closure

  • Project Close-Out Meeting
  • Key outcomes review
  • Archiving

Project Feedback

  • Team feedback
  • Client feedback
  • Feedback evaluation

How to find us